Sanofi is continuing to splash the cash for autoimmune and immunology assets this spring by penning a new deal with ...

Nevertheless, shares in Sanofi have risen on the news, the high price agreed for animal health and the potential for greater dominance in CHC welcomed by the markets. "The new CEO has clearly ...

Sanofi has managed the daunting task faced by managers worldwide: hauling its employees back to the office with minimal fuss. That’s an impressive feat for a company that said last year it was ...

Sanofi CEO Paul Hudson was among seven top business officials from different countries who spoke at the meeting, according to state news agency Xinhua (Chinese). The French pharma in December made ...

The board of directors accepted Hrosz’s resignation during a meeting held on April 9 and expressed appreciation for his ...

Speaking to Fortune last year, Sanofi CEO Paul Hudson described how he used the “Fight Club” approach to encourage employees to begin using its AI agent. Hudson initially got a small group of ...

SK Bioscience CEO Ahn Jae-yong, left, and Sanofi's Jean-Francois Toussant, global head of vaccine research and development, pose for the photo after a signing ceremony. [SK BIOSCIENCE] SK ...

Earendil Labs, an expert in AI-driven research and development of next-generation biologics therapeutics, and Sanofi have ...

Earendil Labs and Sanofi today announced that they have entered into a license agreement for two potential first-in-class ...

CEO, Dren Bio, in the press release. “It has been a privilege to advance our lead platform program, DR-0201 into clinical development and evaluate its potential to achieve potent B-cell depletion. As ...